Ascendis Pharma A/S (ASND):企業の財務・戦略的SWOT分析

◆英語タイトル:Ascendis Pharma A/S (ASND) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15079
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ascendis Pharma A/S (Ascendis) is a biopharmaceutical company that offers drug discovery and development services. The company’s pipeline products include transcon growth hormone, transcon PTH, transcon CNP, and transcon peptides. Ascendis conducts research and develops new drug candidates for treatment. The company’s products are used in the therapeutic areas of diabetes, growth hormone deficiency, endocrinology, and others. It partners with pharmaceutical and biotechnology companies to develop new products. The company has its operations in the US, Germany and Denmark. Ascendis is headquartered in Hellerup, Denmark.

Ascendis Pharma A/S Key Recent Developments

Mar 04,2019: Ascendis Pharma Announces Once-weekly TransCon Growth Hormone Demonstrated Superiority on Primary Endpoint Compared to a Daily Growth Hormone in Phase 3 heiGHt Trial for Pediatric Growth Hormone Deficiency
Nov 28,2018: Ascendis Pharma Announces Positive Preliminary Phase 1 Data for TransCon CNP
Nov 28,2018: Ascendis Pharma reports third quarter 2018 financial results
Nov 08,2018: Ascendis Pharma Announces Formation of VISEN Pharmaceuticals to Develop and Commercialize TransCon™ Endocrinology Rare Disease Therapies in China

This comprehensive SWOT profile of Ascendis Pharma A/S provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Ascendis Pharma A/S including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Ascendis Pharma A/S – Key Information
Ascendis Pharma A/S – Overview
Ascendis Pharma A/S – Key Employees
Ascendis Pharma A/S – Key Employee Biographies
Ascendis Pharma A/S – Key Operational Heads
Ascendis Pharma A/S – Major Products and Services
Ascendis Pharma A/S – History
Ascendis Pharma A/S – Company Statement
Ascendis Pharma A/S – Locations And Subsidiaries
Ascendis Pharma A/S – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Ascendis Pharma A/S – Business Description
Ascendis Pharma A/S – Corporate Strategy
Ascendis Pharma A/S – SWOT Analysis
SWOT Analysis – Overview
Ascendis Pharma A/S – Strengths
Ascendis Pharma A/S – Weaknesses
Ascendis Pharma A/S – Opportunities
Ascendis Pharma A/S – Threats
Ascendis Pharma A/S – Key Competitors

Section 3 – Company Financial Performance Charts

Ascendis Pharma A/S – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Ascendis Pharma A/S, Key Information
Ascendis Pharma A/S, Key Ratios
Ascendis Pharma A/S, Share Data
Ascendis Pharma A/S, Major Products and Services
Ascendis Pharma A/S, History
Ascendis Pharma A/S, Key Employees
Ascendis Pharma A/S, Key Employee Biographies
Ascendis Pharma A/S, Key Operational Heads
Ascendis Pharma A/S, Other Locations
Ascendis Pharma A/S, Subsidiaries
Ascendis Pharma A/S, Key Manufacturing facilities
Ascendis Pharma A/S, Key Competitors
Ascendis Pharma A/S, SWOT Analysis
Ascendis Pharma A/S, Ratios based on current share price
Ascendis Pharma A/S, Annual Ratios
Ascendis Pharma A/S, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Ascendis Pharma A/S, Performance Chart
Ascendis Pharma A/S, Ratio Charts

★海外企業調査レポート[Ascendis Pharma A/S (ASND):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Country Road Group Pty Ltd:企業の戦略的SWOT分析
    Country Road Group Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Marks and Spencer Group plc:企業の戦略・SWOT・財務分析
    Marks and Spencer Group plc - Strategy, SWOT and Corporate Finance Report Summary Marks and Spencer Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Virginia Electric and Power Company:電力:M&Aディール及び事業提携情報
    Summary Virginia Electric and Power Company (Virginia Power), formerly Virginia Public Service Corporation, is a regulated energy utility that generates, transmits, and distributes electricity. It generates electricity from gas, nuclear, oil, coal, renewable, and biomass sources. The company also pr …
  • Sumitomo Seika Chemicals Co Ltd (4008):企業の財務・戦略的SWOT分析
    Sumitomo Seika Chemicals Co Ltd (4008) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Hyundai Steel Co:企業の戦略・SWOT・財務情報
    Hyundai Steel Co - Strategy, SWOT and Corporate Finance Report Summary Hyundai Steel Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • LifeNet Health Inc:医療機器:M&Aディール及び事業提携情報
    Summary LifeNet Health Inc (LifeNet Health) is a non-profit organization that specializes in regenerative medicine. It offers allograft bio-implants and organs for transplantation. The organization specializes in offering organ procurement, tissue banking and transplant services. It provides allogra …
  • LivePerson Inc (LPSN):企業の財務・戦略的SWOT分析
    LivePerson Inc (LPSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • GDI Integrated Facility Services Inc (GDI):企業の財務・戦略的SWOT分析
    Summary GDI Integrated Facility Services Inc (GDI), formery Medwell Capital Corp is a commercial facility service provider. The company’s services include cleaning, food plant sanitation, technical trade services and energy management, healthcare sanitation, hotel support, event support and disaster …
  • AB-Biotics SA (ABB):医療機器:M&Aディール及び事業提携情報
    Summary AB-Biotics SA (AB-Biotics) is a provider of probiotics, pipeline products, specialty dietary supplements, and other functional ingredients. The company’s products comprise iron-containing ingredients, lactobacillus plantarum, probiotic products, gastrointestinal treatment products, proprieta …
  • Calfrac Well Services Ltd (CFW):企業の財務・戦略的SWOT分析
    Calfrac Well Services Ltd (CFW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • United Biscuits (UK) Limited:企業の戦略・SWOT・財務情報
    United Biscuits (UK) Limited - Strategy, SWOT and Corporate Finance Report Summary United Biscuits (UK) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Kiadis Pharma NV (KDS):企業の財務・戦略的SWOT分析
    Summary Kiadis Pharma NV (Kiadis) is a biopharmaceutical company that develops and markets cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. The company offers cellular products including ATIR101 and ATIR201 for infusion. Its ATIR101 lowers the risks …
  • Chemical Company of Malaysia Bhd (CCM):製薬・医療:M&Aディール及び事業提携情報
    Summary Chemical Company of Malaysia Bhd (CCM) is an industrial and specialty chemicals company. It manufactures and markets chlor-alkali and coagulant products; markets industrial and specialty chemicals; and produces polymer coating. The company’s chemical offerings find application in petrochemic …
  • Advocate Aurora Health Care:企業の戦略的SWOT分析
    Advocate Aurora Health Care - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Beaver Aerospace & Defense, Inc.:企業の戦略・SWOT・財務情報
    Beaver Aerospace & Defense, Inc. - Strategy, SWOT and Corporate Finance Report Summary Beaver Aerospace & Defense, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • EMD Serono Inc-製薬・医療分野:企業M&A・提携分析
    Summary EMD Serono Inc (EMD), formerly Serono Inc, a subsidiary of Merck KGaA is a healthcare products provider that offers oncology products. The company offers neurology and immunology; metabolic endocrinology, fertility and oncology products. It offers neurology and immunology products to find ne …
  • Argon Medical Devices Inc-医療機器分野:企業M&A・提携分析
    Summary Argon Medical Devices Inc (Argon) is a medical device company that manufactures and supplies products for the dialysis and others. The company provides arterial catheters, temporary pacing electrode trays, pulmonary artery and thermodilution catheters, and single lumen central venous cathete …
  • Kinnov Therapeutics SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Kinnov Therapeutics SAS (Kinnov) is a research and development company that discovers and develops therapies against addiction. The company provides pipeline product such as KT-110, a pharmaceutical composition used as a therapy for addiction diseases. Its antagonist of alpha1-adrenergic rec …
  • Rift Energy Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary Rift Energy Corp (Rift Energy) is an upstream oil and gas exploration and development company that acquires, explores, develops and produces oil and gas assets in east and central Africa. The company's assets include Block L19 in Kenya, which covers approximately 9,000 sq km acres of land in …
  • Cargotec Oyj:企業のM&A・事業提携・投資動向
    Cargotec Oyj - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cargotec Oyj Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆